Bioabsorbable Stents Market 2021-2027 – Increasing Focus on Clinical Trials and Technological Advancements
Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026

Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026

The bioabsorbable stents market is set to grow from 2021 to 2027, driven by technological advancements and an aging population.
Bioabsorbable Stents Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Bioabsorbable Stents Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/897
A bioabsorbable Stent is a metal tube with an absorbent gel. Bioabsorbable stent devices also referred to as biodegradable stents are coronary stents that can fully dissolve in the body. These stent devices are typically used in the treatment of patients suffering from coronary artery disease (CAD) and peripheral artery disease (PAD). As per the Centers for Disease Control and Prevention (CDC), in 2017, around 365,914 people died due to coronary artery disease in the U.S. As per the same source, around 6.5 million people aged 40 years and above in the U.S. from PAD each year. This, in turn, the demand for stent devices has increased, which can augment growth of the bioabsorbable stents market.
Another key factor fueling the demand for bioabsorbable stents is the rapidly growing geriatric population. Elderly people are most vulnerable to different types of chronic diseases namely PAD and CAD. As per the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Hence, such factors can potentially stimulate growth of the bioabsorbable stents market. Recently, in February 2019, Biotronik received the U.S. Food and Drug Administration (FDA) approval for its ultrathin bioabsorbable coronary stents for the treatment of patients with CAD.
There are two common types of stents namely magnesium-based and synthetic. Both are typically made from commercially available magnesium-based scaffolds, which have the advantage of being lightweight and durable while still being flexible enough to allow for expansion when needed. In recent years, medical researchers have been working to fabricate carbon-based scaffolds, which have some of the same advantages as the magnesium scaffolds but also exhibit some of the same qualities of high-tech glass materials. When it comes to regional impact, North America seems to be gaining significant traction in the bioabsorbable stents market. This is typically due to rapidly growing geriatric population and increased awareness for the treatment of coronary ailments. On the contrary, Asia Pacific is exhibiting a positive outlook due to rising population of extended levels of cholesterol.
As technology and research continue to advance the bioabsorbable stents that are used to combat many different ailments around the world, the need for certification by the American Society for Testing and Materials (ASTM) will become more prevalent. Regardless of these pointers, certain factors can pose a major challenge in growth of the said market. For instance, there is the presence of alternatives to bioabsorbable stents such as laser angioplasty and many patients tend to choose these options. Besides, product withdrawals and high risk of complications can limit growth of the bioabsorbable stents market.
Top Key Players Include In Bioabsorbable Stents Market: STENTYS SA, Abbott laboratories, Biotronik, Elixir Medical Corporation, Reva Medical Incorporated, Kyoto Medical Planning Cooperative Limited, Amaranth Medical Incorporated, Boston Scientific Co., and Microsoft scientific corporation.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/897
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Bioabsorbable Stents Market 2021-2027 – Increasing Focus on Clinical Trials and Technological Advancements appeared first on Gatorledger.
The article discusses the growth and factors influencing the bioabsorbable stents market from 2021 to 2027.
Technological advancements, rising cases of CAD and PAD, and an aging population drive the market.
Challenges include alternatives like laser angioplasty and risks of complications.
Explore more articles in the Research Reports category











